Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson Collaborates with Aduro BioTech
Yahoo/Zacks.com
Friday, May 30, 2014 - 12:22pm
tags:
JNJ, Aduro BioTech, prostate cancer
AstraZeneca’s resistance efforts rely on cancer drug advances
FT.com
Friday, May 30, 2014 - 10:37am
tags:
AstraZeneca, MEDI4736
[video]Could This be Pfizer's Best Incoming Drug?
Motley Fool
Friday, May 30, 2014 - 10:15am
tags:
Pfizer, palbociclib, breast cancer
Scorned Pfizer Should Forget AstraZeneca and Buy Celgene Instead
Motley Fool
Friday, May 30, 2014 - 10:12am
tags:
Pfizer, AstraZeneca, Celgene, M&A
Italy to seek $1.6 billion damages from Roche, Novartis
Marketwatch
Thursday, May 29, 2014 - 1:14pm
tags:
Italy, Roche, Novartis, antitrust, Lucentis
Substance Over Style: How Niche Companies Alliqua And Horizon Are Being Overlooked
Seeking Alpha
Thursday, May 29, 2014 - 10:39am
tags:
Alliqua BioMedical, Horizon Pharma, wound care, arthritis
What Price Innovation? The Sovaldi Saga
Forbes
Thursday, May 29, 2014 - 9:43am
tags:
innovation, Sovaldi, Gilead Sciences, drug pricing, hepatitis C
Chelsea Therapeutics - Going Private Transaction Provides Significant Upside
Seeking Alpha
Thursday, May 29, 2014 - 9:35am
tags:
Chelsea Therapeutics, Lundbeck
Mylan launches generic version of GlaxoSmithKline's Malarone tablets
The Fly on the Wall
Thursday, May 29, 2014 - 9:28am
tags:
generics, Mylan, GSK, Malarone, malaria
Today's Top Biotech Stocks to Watch: Intercept Pharmaceuticals and VIVUS
Motley Fool
Thursday, May 29, 2014 - 9:17am
tags:
Vivus, Intercept Pharmaceuticals, M&A, Aspen Investments, OCA
Boston Therapeutics initiates Phase IIb study of Sugardown
The Fly on the Wall
Thursday, May 29, 2014 - 8:54am
tags:
Boston Therapeutics, Sugardown, diabetes
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thursday, May 29, 2014 - 8:52am
tags:
cancer immunotherapy, Merck, MK-3475, Roche, Yervoy, Bristol-Myers Squibb, Merck KGaA, AstraZeneca
Glaxo China sales staff seeks reimbursement for 'bribes,' FT says
The Fly on the Wall
Thursday, May 29, 2014 - 8:50am
tags:
GSK, bribery, China
Why Pfizer Will Never Be the Same Again
Motley Fool
Wednesday, May 28, 2014 - 7:51pm
tags:
Pfizer, AstraZeneca, restructuring
Medtronic settles U.S. kickbacks case over pacemakers
Yahoo/Reuters
Wednesday, May 28, 2014 - 4:43pm
tags:
pacemakers, Medtronic
Insurers scrutinize drug costs after $84,000 Sovaldi surprise
Yahoo/Reuters
Wednesday, May 28, 2014 - 2:01pm
tags:
drug pricing, insurance, Sovaldi, Gilead Sciences
St. Jude to Buy CardioMEMS after FDA Sensor Approval
Bloomberg
Wednesday, May 28, 2014 - 1:54pm
tags:
St. Jude Medical, FDA, CardioMEMS, M&A, HF System
Analysis: A weakened Pfizer signals that it's prepped to wheel and deal
Fierce Biotech
Wednesday, May 28, 2014 - 11:42am
tags:
Pfizer
Stryker denies Smith & Nephew takeover rumors
Mass Device
Wednesday, May 28, 2014 - 11:40am
tags:
Smith & Nephew, M&A, Stryker, devices
A Greek Lawyer Managing a Little-Known Investment Fund Wants to Buy Vivus for $640 Million
TheStreet.com
Wednesday, May 28, 2014 - 11:39am
tags:
Vivus, M&A, Aspen Investments

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.